Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling

NCT00132119 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

233

Enrollment

INDUSTRY

Sponsor class

Conditions

Pathological Gambling

Interventions

DRUG: nalmefene HCl
OTHER: Placebo

Sponsor

Somaxon Pharmaceuticals